GLUCOKINASE-MATURITY ONSET DIABETES OF THE YOUNG (GCK-MODY)

Clinical trials for GLUCOKINASE-MATURITY ONSET DIABETES OF THE YOUNG (GCK-MODY) explained in plain language.

Never miss a new study

Get alerted when new GLUCOKINASE-MATURITY ONSET DIABETES OF THE YOUNG (GCK-MODY) trials appear

Sign up with your email to follow new studies for GLUCOKINASE-MATURITY ONSET DIABETES OF THE YOUNG (GCK-MODY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could less insulin mean a healthier heart for type 1 diabetics?

Disease control Recruiting now

This study is testing if using an add-on pill to lower the amount of insulin needed can improve heart and blood vessel health in people with type 1 diabetes. Researchers will compare people with type 1 diabetes to people with a milder genetic form of diabetes and healthy voluntee…

Matched conditions: GLUCOKINASE-MATURITY ONSET DIABETES OF THE YOUNG (GCK-MODY)

Phase: EARLY_PHASE1 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

GLUCOKINASE-MATURITY ONSET DIABETES OF THE YOUNG (GCK-MODY)

Get alerted when new GLUCOKINASE-MATURITY ONSET DIABETES OF THE YOUNG (GCK-MODY) trials appear

Could less insulin mean a healthier heart for type 1 diabetics?